1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B0824F8F2A40C9EF85256DCD00638F57
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/gene-maps-dna-technology-survey-analysis?opendocument
18
19opendocument
2054.226.175.101
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services New Product Development New Product Development: Structure and Functions

Gene Maps: DNA Technology Survey Analysis

DB Image

ID: 4510


Features:

Metrics, Graphics, Detailed Process Map


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 39-slide presentation includes findings and forecasting on gene maps and DNA technology. Featured are survey results predicting the future of the field, key pharmaceutical companies, early stage DNA technology companies, academic and government labs, disease states, locations for diagnostics as well as a technology roadmap. This research originated from Best Practice, LLC's consulting services.

Industries Profiled:
Diagnostic; Biotech; Pharmaceutical; Electronics; Health Care; Academic; Research


Companies Profiled:
Boehringer-Ingelheim; Vysis; Stratagene; Celera; Sima; Pharmagenics; Qiagen; Curis; Nanogen; Amersham; Merck; Invitrogen; Human Genome Sciences; Genzyme; Genomyx; Exelixis; CuraGen; Clontech; Canjii; Roche Molecular Biochemicals; Affymetrix; Yale; University of North Carolina; University of Washington; Stanford University; Johns Hopkins; Harvard University; Harvard Medical School; Florida Atlantic University; Dana Farber Cancer Institute; Cold Spring Harbor; Cal Tech; ATP


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.